ADHD Coronavirus Eosinophilic Esophagitis Influenza

ADHD Coronavirus Eosinophilic Esophagitis Influenza

View More Allergy Cardiology Diabetes Gastroenterology Geriatric Medicine Infectious Disease Neurology Psychiatry Pulmonology Rheumatology

Allergy Cardiology Diabetes Gastroenterology Geriatric Medicine Infectious Disease Neurology Psychiatry Pulmonology Rheumatology

Insights News Network Peer Exchange Peers & Perspectives Post Conference Perspectives

Insights News Network Peer Exchange Peers & Perspectives Post Conference Perspectives

Medical World News

Medical World News Podcasts Videos Webinars

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Partners CME/CE

Exclusive Content

Interactive Tools

Physician's Money Digest

Exclusive Content Interactive Tools Live Events Physician's Money Digest Press Release Publications Sponsored

About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions

© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.

Spotlight

ADHD
Coronavirus
Eosinophilic Esophagitis
Influenza

ClinicalSee All >

Allergy
Cardiology
Diabetes
Gastroenterology
Geriatric Medicine
Infectious Disease
Neurology
Psychiatry
Pulmonology
Rheumatology

Video Series

Insights
News Network
Peer Exchange
Peers & Perspectives
Post Conference Perspectives

hcplive podcasts

About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions

© 2021 MJH Life Sciences^™ and HCPLive - Clinical news for connected physicians. All rights reserved.

Best Practices and Treatment Options to Manage Heart Failure

April 30, 2020

Previous Video Next Video

Related Content:

Peer ExchangeHeart Failure

Waqar Khan, MD: Coronary Heart Disease During COVID-19

Waqar Khan, MD: Coronary Heart Disease During COVID-19

Dapagliflozin Reduces Cardiovascular Death or Worsening Heart Failure

Dapagliflozin Reduces Cardiovascular Death or Worsening Heart Failure

FDA Approves New Indication for Entresto for Patients with LVEF Below Normal

FDA Approves New Indication for Entresto for Patients with LVEF Below Normal

x